Research and experimental development on natural sciences and engineering
BIOSYNTECH AS
Revenue 2024
NOK 0
Operating profit
NOK −137,000
Equity
NOK 37,000
Incorporated
2021
Share capital
NOK 330,000
Roles
Regnskapsfører
Styrets lederØystein Selen
StyremedlemTom Kristian Hoffmann
StyremedlemGunnar Sæthern Eskeland
StyremedlemDag Hjelle
StyremedlemJørn Morten Einen
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| SOLUSINET AS | 50.0% | 1650.000000 | 2025 |
| TOM KRISTIAN HOFFMANN | 20.0% | 660.000000 | 2025 |
| MEDCIS AS | 20.0% | 660.000000 | 2025 |
| PROMØRE AS | 6.8% | 225.000000 | 2025 |
| FLAVIRAMULUS HOLDING AS | 2.1% | 70.000000 | 2025 |
| UTMARKSBEITE AS | 1.1% | 35.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.